Minocycline Hydrochloride 115 mg Tablets
Ascend Laboratories is recalling Minocycline Hydrochloride 115 mg tablets due to failed dissolution specifications.
Contact your healthcare provider or pharmacist regarding alternative treatment options. Do not discontinue use of this medication without consulting a medical professional.
Why it was recalled
Ascend Laboratories is recalling Minocycline Hydrochloride Extended-Release Tablets due to failed dissolution specifications. An out-of-specification result was observed during the 9th month of stability testing.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30
- UPC
- 25141635
- Recall #
- D-0597-2026
Where it was sold
Distributed nationwide.
Official source
Other recent recalls from Ascend Laboratories, LLC
Editorial summary by Recall Canary · last updated 2026-06-18 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification